RMD
Asset Logo

ResMed Inc.

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💰

0.53%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

57
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 8,160 full-time employees. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The company also offers software solutions for a variety of out-of-hospital care providers. The firm has two segments: Sleep and Respiratory Care and the Software-as-a-Service. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The firm's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices and cloud-based software informatics solutions.

📈 Performance

Price History

+1228.92%

1M

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

0.53%

💰 Annual Dividend Earnings Per $1,000 invested**

$5.28

💰 Most Recent Dividend Franked Percentage Estimate

0.00%

💰 Average Dividend Franked Percentage Estimate

0.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.00

0.00%

2023

$0.09

0.00%

2022

$0.17

0.00%

2021

$0.15

0.00%

2020

$0.16

0.00%

2019

$0.15

0.00%

2018

$0.14

0.00%

2017

$0.12

0.00%

2016

$0.12

0.00%

2015

$0.12

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🍃 Environmental, Social and Governance scores ℹ️

🌳

Environmental Score
65

A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution

🕊️

Social Score
46

An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.

⚖️

Governance Score
54

An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.

🤓 Advanced information

Technical Info

💰 Price*

$33.09

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in RMD

57

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in RMD

487 days
RMD investor breakdown
💵 Income of investors

More than 200k

150k - 200k

9%

100k - 150k

21%

50k - 100k

47%

Less than 50k

15%
👶 Age of investors

18 - 25

26 - 34

47%

35 - 90

47%
🙋 Legal gender of investors

Female

42%

Male

58%

Pearlers who invest in RMD also invest in...

Vanguard Australian Shares Index Etf

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

📊 Share price

$104.08 AUD

NULL GLOBAL

NULL EX AUSTRALIA

NULL BETA

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

📊 Share price

$57.36 AUD

NULL GLOBAL

NULL SMART BETA

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,000 full-time employees. The Company’s areas of focus and exploration include rare and serious diseases, influenza vaccines, plasma collection, and therapies for iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments. The Company’s CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency, dialysis and nephrology and rare diseases. The Company’s geographical areas of operation include Australia, the United States of America, Germany, the United Kingdom, Switzerland, and China. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

📊 Share price

$308.11 AUD

NULL HEALTH

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

📊 Share price

$43.11 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

Want more shares? Try these...

Resource Mining Corp. Ltd. is a minerals exploration company, which focuses on exploration of gold, copper, nickel and base metal mineralization. The company is headquartered in Subiaco, Western Australia. The firm's Kabulwanyele Nickel Project (KNP) is located approximately 45 kilometers (km) south-west of Mpanda, the administrative center for the Katavi Region in Western Tanzania, in an area of known nickel mineralization and approximately 35 km from the western shore of Lake Tanganyika. The KNP comprises two granted Prospecting Licenses, including PL/11534/2021 and PL/11535/2021. Its Massive Nickel projects include the Kabanga Nickel Project, Kapalagulu Project, the Liparamba Project, Kitai Project and Mbinga Nickel Project, totaling over 1,415 square kilometers. The company also has Finnish projects, including Roussakero Nickel Project, Hirvikallio Lithium Project and Kola Lithium Project.

📊 Share price

$0.06 AUD

Resolution Minerals Ltd. operates as a resource company, which engages in the acquisition, exploration, and development of cobalt mineral projects. The company is headquartered in Adelaide, South Australia. The company went IPO on 2017-09-22. The firm's projects include 64North Project, George Project, Wollogorang Project and Benmara Project. The 64North Project is situated in the heart of the Tintina gold belt, which stretches from the Yukon in Canada to the Alaskan Coast. The George Project covers a large patch of dirt (approximately 2,839 square kilometers) in central South Australia. The Wollogorang Project is prospective for near surface sedimentary hosted copper and cobalt resources. The company covers over 4000 square kilometers in the North-East of the Northern Territory and is located within the McArthur Basin, which hosts the McArthur River lead-zinc Mine. The Benmara Project is complementary to its nearby Wollogorang Project, which is prospective for sedimentary hosted battery metals copper and cobalt.

📊 Share price

$0.01 AUD

Renergen Ltd. operates as an investment holding company, which engages in the provision of alternative and renewable energy sectors. The firm is also focused on delivering helium and domestic natural gas in South Africa and Sub-Saharan Africa. The firm's segments include Tetra4, Cryovation and Corporate head office. Tetra4 segment explores for, develops and sells compressed natural gas (CNG) to the South African market. Cryovation segment offers safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power. The Company’s projects include Virginia Gas project (Tetra4). Its Tetra4 project comprises exploration and production rights of approximately 187 000 hectares (ha) of CNG fields across Welkom, Virginia and Theunissen, in the Free State Province and Mpumalanga Province in the town of Evander. The firm's subsidiaries include Tetra4 Proprietary Limited.

📊 Share price

$1.59 AUD

Resimac Group Ltd. engages in the provision of mortgage origination and management of home loans. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-03-19. The firm is focused on distributing prime and specialist products across multiple channels. The company operates primarily in Australia and New Zealand, originating a quality loan portfolio, loan servicing capability, and global funding program. The company offers a suite of lending products to consumers and commercial borrowers across its wholly owned subsidiaries. These products include residential home loans, consumer finance, and small and medium enterprises (SME) finance. The company also offers home loans directly to consumers via its homeloans.com.au brand, with a range of smart and transparent home loan solutions that borrowers can apply for using its end-to-end online application. The company offers a range of financial solutions for SMEs and commercial borrowers through its Resimac Asset Finance brand. Its subsidiaries include Resimac Asset Finance Pty Limited and RESIMAC NZ Home Loans Ltd.

📊 Share price

$0.91 AUD
Compare
Add to watchlist